Is Hyperfine, Inc. (HYPR) a Buy, Sell, or Hold?
NASDAQ : HYPR
Hyperfine, Inc.
$0.9539 USD
$0.0 (0.01%)
- Volume
- 311.59K
- Average Volume
- 1.07M
- Market Capitalization
- $80.33M
- P/E Ratio
- -2.31
- Dividend Yield
- 0.00%
- Price Target
- $1.60
- Year High
- $2.22
- Year Low
- $0.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.52
Company Overview
NASDAQ
Maria Degois Sainz
Medical - Specialties
Healthcare
HYPR
102
US
USD
Liquidity Metrics
0.39
5.52
4.90
4.02
0.00
Sales & Valuation
$13.56M
5.24
2.71
-2.80
-0.29
Profitability
-$0.43
-$35.57M
-226.88%
-226.88%
-101.28%
-57.64%
P/E Metrics
-2.31
-0.08
-0.08
Analyst Price Target & Rating
$1.60
$1.60
$1.60
1/5
4 Analysts
-40.38%
Financial Health Scores
-6.73
3/9
$45.88M
$60.34M
$25.98M
-$34.7M
Key Metrics (TTM)
$52.91M
3.45
-1.60
5.52
-101.28%
-68.91%
-37.32%
-35.68%
225 days
Company Executives
| Name | Title |
|---|---|
| Jonathan Rothberg | Founder & Vice Chairman |
| Maria Sainz | Chief Executive Officer, President & Director |
| Rafael Donnay | Senior Vice President of Hospital Business |
| Rafael O'Halloran | Vice President of Technology |
| Rob Fasciano | Chief Regulatory & Quality Officer |
| Brett Hale | Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary |
| Chip Truwit FACR | Senior Vice President of Office Strategy and Partnerships |
| Thomas Teisseyre | Chief Operating Officer |
| Edmond Knopp | Chief Medical Officer |
Poll Results
No votes yet today — be the first to share your view!
About Hyperfine, Inc. (NASDAQ:HYPR) Stock
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut. ...
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
2026-07-23 16:05:00
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine will report Q2 2026 financial results Thur., Aug. 6, 2026. Management will host a corresponding conference call at 1:30 PM PT/4:30 PM ET.
Hyperfine Announces European Launch of Next-Generation Swoop® System
2026-07-01 08:15:00
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine initiates the launch of the next-gen Swoop® system in Europe, beginning global expansion of its most advanced portable MRI technology. .
2026-06-22 08:15:00
GUILFORD, Conn.--(BUSINESS WIRE)--Leading neurosurgeons will help guide the role of the Swoop® system in neurosurgical care, including workflow, product capabilities, and evidence.
2026-06-18 09:00:00
[url="]Hyperfine, Inc.[/url] (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powere
2026-06-18 08:15:00
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces Swoop® system scan volume milestones at key hospitals and neurology clinics, demonstrating accelerating adoption across the US.
2026-06-05 15:22:54
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
2026-05-26 09:00:00
[url="]Hyperfine, Inc.[/url] (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powere
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
2026-05-26 08:15:00
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine is expected to join broad-market Russell 3000® Index & small-cap Russell 2000® Index at the conclusion of June 2026 Russell Reconstitution.
Frequently Asked Questions
-
What is the current Hyperfine, Inc. (HYPR) stock price?
-
Hyperfine, Inc.(NASDAQ:HYPR) stock price is $0.9539 in the last trading session. During the trading session, HYPR stock reached the peak price of $2.22 while $0.85 was the lowest point it dropped to. The percentage change in HYPR stock occurred in the recent session was 0.01% while the dollar amount for the price change in HYPR stock was $0.0.
-
HYPR's industry and sector of operation?
-
The NASDAQ listed HYPR is part of Medical - Specialties industry that operates in the broader Healthcare sector.
-
Who are the executives of HYPR?
-
Jonathan Rothberg | Founder & Vice Chairman
Maria Sainz | Chief Executive Officer, President & Director
Rafael Donnay | Senior Vice President of Hospital Business
Rafael O'Halloran | Vice President of Technology
Rob Fasciano | Chief Regulatory & Quality Officer -
How many employees does HYPR have?
-
Number of HYPR employees currently stands at 102. HYPR operates from 351 New Whitfield Street, Guilford, CT 06437, US.
-
Link for HYPR official website?
-
Official Website of HYPR is: https://www.hyperfinemri.com
-
How do I contact HYPR?
-
HYPR could be contacted at phone #203-458-7100 and can also be accessed through its website. HYPR operates from 351 New Whitfield Street, Guilford, CT 06437, US.
-
How many shares of HYPR are traded daily?
-
The average number of HYPR shares traded daily for last 3 months was 1.07M.
-
What is the market cap of HYPR currently?
-
The market value of HYPR currently stands at $80.33M with its latest stock price at $0.9539